Northern Illinois University

Huskie Commons
Faculty Peer-Reviewed Publications

Faculty Research, Artistry, & Scholarship

12-6-2022

Construction and case study of a novel lung cancer risk index
Ali Faghani
faghani.al@gmail.com

Lei Guo
Northern Illinois University, z1935842@students.niu.edu

Mahdi Vaezi
Northern Illinois University

Margaret Wright Geise
University of Illinois at Chicago, mewright@uic.edu

M. Courtney Hughes

Follow this and additional works at: https://huskiecommons.lib.niu.edu/allfaculty-peerpub
Part of the Other Public Health Commons

Recommended Citation
Faghani, Ali; Guo, Lei; Vaezi, Mahdi; Geise, Margaret Wright; and Hughes, M. Courtney, "Construction and
case study of a novel lung cancer risk index" (2022). Faculty Peer-Reviewed Publications. 1105.
https://huskiecommons.lib.niu.edu/allfaculty-peerpub/1105

This Article is brought to you for free and open access by the Faculty Research, Artistry, & Scholarship at Huskie
Commons. It has been accepted for inclusion in Faculty Peer-Reviewed Publications by an authorized administrator
of Huskie Commons. For more information, please contact jschumacher@niu.edu.

(2022) 22:1275
Faghani et al. BMC Cancer
https://doi.org/10.1186/s12885-022-10370-4

Open Access

RESEARCH

Construction and case study of a novel lung
cancer risk index
Ali Faghani1†, Lei Guo2† , Margaret E. Wright3 , M. Courtney Hughes4   and Mahdi Vaezi1*   

Abstract
Purpose: This study constructs a lung cancer risk index (LCRI) that incorporates many modifiable risk factors using an
easily reproducible and adaptable method that relies on publicly available data.
Methods: We used meta-analysis followed by Analytic Hierarchy Process (AHP) to generate a lung cancer risk index
(LCRI) that incorporates seven modifiable risk factors (active smoking, indoor air pollution, occupational exposure,
alcohol consumption, secondhand smoke exposure, outdoor air pollution, and radon exposure) for lung cancer. Using
county-level population data, we then performed a case study in which we tailored the LCRI for use in the state of
Illinois (LCRIIL).
Results: For both the LCRI and the LCRIIL, active smoking had the highest weights (46.1% and 70%, respectively),
whereas radon had the lowest weights (3.0% and 5.7%, respectively). The weights for alcohol consumption were 7.8%
and 14.7% for the LCRI and the LCRIIL, respectively, and were 3.8% and 0.95% for outdoor air pollution. Three variables
were only included in the LCRI: indoor air pollution (18.5%), occupational exposure (13.2%), and secondhand smoke
exposure (7.6%). The Consistency Ratio (CR) was well below the 0.1 cut point. The L CRIIL was moderate though significantly correlated with age-adjusted lung cancer incidence (r = 0.449, P < 0.05) and mortality rates (r = 0.495, P < 0.05).
Conclusion: This study presents an index that incorporates multiple modifiable risk factors for lung cancer into one
composite score. Since the LCRI allows data comprising the composite score to vary based on the location of interest, this measurement tool can be used for any geographic location where population-based data for individual risk
factors exist. Researchers, policymakers, and public health professionals may utilize this framework to determine areas
that are most in need of lung cancer-related interventions and resources.
Keywords: Lung cancer, Risk factors, Analytic hierarchy processes, Meta-analysis, Risk index
Introduction
Cancer is the second leading cause of death in the US,
with lung cancer accounting for almost one-quarter of
these deaths. The American Cancer Society estimates
that 236,740 new lung cancers will be diagnosed in 2022,
and this disease will claim the lives of more than 130,000
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men and women [1]. Numerous studies have examined
risk factors for lung cancer, with smoking being the single largest contributor to the disease [2–11]. Other established risk factors include age [12], secondhand smoke
exposure [13], environmental exposures (radon [14],
indoor and outdoor air pollution [15, 16]), occupational
exposures [17], diet [18], alcohol consumption [19],
genetic predisposition [20], previous lung disease [21],
and arsenic exposure [22]. Many of these risk factors are
modifiable, including active smoking and secondhand
smoke exposure, environmental exposures, occupational
exposures, alcohol consumption, and diet [23].
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Fig. 1 Flowchart showing the process used to generate the Lung Cancer Risk Index (LCRI). AHP = Analytic Hierarchy Process, CI = confidence
interval, OR = odds ratio, RR = relative risk

Although many studies have investigated associations
between individual risk factors and lung cancer risk or
mortality [20–32], less is known about how these factors interact to influence the development and progression of the disease. Some studies have examined
interactions between smoking and one other risk factor,
such as radon, alcohol consumption, family history, previous lung disease, or some component of diet [33]. To
our knowledge, there are few, if any, studies that simultaneously investigated the contribution of more than
two modifiable risk factors for lung cancer. This may be
because epidemiologic studies are often limited in their
ability to consider multiple factors simultaneously, given
limited sample sizes and ranges of exposures within their
study populations [34].
To address this gap, we constructed a Lung Cancer Risk
Index (LCRI) that incorporates several modifiable risk
factors using Meta-Analytic Hierarchy Process (MetaAHP). While this approach has been used in the soil science field [35], it has not been commonly employed in
the health sciences. Meta-AHP may be superior to a traditional principal component analysis approach because
Meta-AHP can effectively extract essential variables and
assign weights more precisely. We tailored this index for
use in a case study of the state of Illinois; the LCRIIL was
created using publicly available county-level data for all
102 Illinois counties. We then evaluated the correlation
between the LCRIIL and reported lung cancer incidence
and mortality rates. We provide researchers with an easily reproducible and adaptable method that uses publicly available data to generate a composite measure that
integrates multiple modifiable risk factors for lung cancer. This measure can be tailored for any geographic area

and is potentially widely applicable. Public health officials
and policymakers may consider using this measure when
making decisions regarding lung cancer-related interventions and resource allocation in their communities.

Methods
Figure 1 shows the process that we used to generate the
lung cancer risk index (LCRI). Each step in the figure is
explained in detail below.
Step 1: identify relevant articles: search strategy and article
selection

Using the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) guidelines [36],
we conducted searches of PubMed (including MEDLINE)
and Google Scholar for full-length articles that were published between January 1990 and April 2021. We utilized
the following keyword strings to capture relevant studies: “lung cancer” in conjunction with one of the following—“smoking,” “passive smoking,” “secondhand smoke,”
“radon,” “occupation,” “air pollution,” “alcohol consumption,” or “risk factors.” We did not include diet in our
index because the World Cancer Research Fund (WCRF)
and American Institute for Cancer Research (AICR)
consider there to be “limited evidence” that diet is a risk
factor for lung cancer [37]. We chose to exclude arsenic
exposure from our index because the US public water
supply levels are kept below 50 µg/L [38, 39], which is far
below concentrations associated with increased lung cancer risk [22, 40]. Nevertheless, researchers in other countries should consider adding arsenic to an LCRI adapted
for use in their locations. We assessed the quality of the
articles included in the present study using appraisal
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Fig. 2 Flowchart of search methodology and article selection

checklists and criteria of quality recommended by JBI
(formerly known as "Joanna Briggs Institute"), an international organization focused on improving evidence as
it relates to the feasibility, appropriateness, meaningfulness, and effectiveness of healthcare interventions [41].
As shown in Fig. 2, the initial literature search yielded
1197 articles. We removed 268 articles that were duplicates, not peer-reviewed prior to publication, or written in languages other than English. We then reviewed
the abstracts of the 929 remaining articles and applied
the study inclusion criteria: (1) randomized controlled
trial, prospective cohort study, retrospective cohort
study, case-cohort study, case–control study, or nested
case–control study; (2) reported the relative risk (RR) or
odds ratio (OR) associated with increased risk (i.e., RR or
OR > 1, which is a requirement of the Analytic Hierarchy
Process (AHP) model); and (3) reported 95% confidence
intervals (CIs). After excluding 877 articles that did not
meet the inclusion criteria specified above, at least two
researchers reviewed the full text of the remaining 52
manuscripts [42].
Steps 2a / 2b: meta‑analysis

The second step in creating our index was to extract the
adjusted OR and RR from all 52 articles for each lung
cancer risk factor examined (Additional file Table 1).

Next, a weighted average of study-specific estimates
using inverse variance weights was derived for each risk
factor [43] to increase the accuracy of outcomes [44, 45].
The potential for publication bias was evaluated by funnel plots and the methods described by Egger et al. [46]
and Begg et al. [47]. Using a random-effects model, we
analyzed the studies and considered heterogeneity and
within-study variance [48]. We evaluated heterogeneity
using Cochrane’s Q-statistic [49] and the I2 inconsistency
statistical tests [50].
We considered the OR to be a good approximation of
the RR for our analysis, which is reasonable when the
outcome is rare [51]. We used the OR and the logOR and
calculated standard errors (SEs) as data points for the
meta-analysis. All statistical manipulations were conducted using the meta-analysis package for R (metaphor
Version 2, MA, USA).
Steps 3a‑3c: Analytic Hierarchy Process (AHP)

The third step in creating our index was to use the results
of our meta-analysis as inputs for the AHP analysis and
to generate weights for each risk factor. AHP is one of
the most widely used Multi-Criterion Decision Making (MCDM) methods [52] and has been increasingly
implemented in health care, including cancer research
[53–57]. AHP can quantitatively prioritize risk factors
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by producing weights for each factor, making it an ideal
method to apply in this study. For each included modifiable risk factor, we used the OR derived from our metaanalysis as input variables in the AHP. Using the values
from meta-analysis and the assessment matrix, we created the pair-wise comparison matrix (i.e., a matrix to
compare risk factors in pairs to evaluate their relative
importance). We created an assessment matrix with
numbers that pair with different importance levels. For
example, 1, 3, 5, 7, and 9 pair with equal, weak, obvious,
intense, and extreme importance, while 2, 4, 6, and 8 pair
with intermediate importance, respectively [58] (Additional file Table 1).
The relative importance of smoking versus all other
included risk factors was assigned considering the assessment matrix. This step was then repeated for all other
remaining risk factors. Next, an n by n matrix was created where n represented the number of modifiable risk
factors. Next, we solved the linear system, where A is the
coefficient matrix using Eq. 1:

AX = Xor(A − In )X = 0

(1)

where A is the comparison matrix of order n, and λ
is one of its eigenvalues. X represents the eigenvector
of A associated with λ, and A-λIn represents the matrix
coefficient. We used MATLAB (MathWorks, Massachusetts, USA) to calculate the eigenvalues and eigenvectors of the matrix [59]. Then we used the derived
eigenvector to specify the weights of each risk factor

Table 1 Overall effect size and final weights for modifiable risk
factors included in the Lung Cancer Risk Index (LCRI)
No

Risk factor

Overall effect
size from metaanalysis

Weights
used in LCRI
(%)

1

Active smoking

8.63

46.1

2

Indoor air pollution

1.76

18.5

3

Occupational exposure

1.60

13.2

4

Alcohol consumption

1.45

7.8

5

Secondhand smoke exposure 1.43

7.6

6

Outdoor air pollution

1.25

3.8

7

Radon exposure

1.24

3.0

Total

Saaty [60] has presented the values for RI considering the matrix size. Also, Saaty [60] suggested that
the CR needs to be less than 0.1 to produce consistent
results.

Results
As shown in Table 1, the process that we used to create
the LCRI yielded the highest weight for active smoking
(46.1%) and the lowest weight for radon exposure (3.0%).
The CR of the AHP analysis for the present study was
0.07, well below the 0.1 cut point that demonstrates consistency of the analysis.
We used the weights in Table 1 to produce the LCRI:

LCRI = 0.461A1 + 0.185A2 + 0.132A3 + 0.078A4 + 0.076A5 + 0.038A6 + 0.030A7
where the eigenvector represented the index coefficient. Next, we estimated the contribution of each risk
factor to lung cancer. We then calculated the z score
and considered the z score as the corresponding value
in the index. Finally, z-scores were converted to percentiles for mapping purposes.
We used the Consistency Ratio (CR) to verify the reliability of our results. To do this, we first calculated the
Consistency Index (CI1) using the following equation:

CI 1 = (max − n)/(n − 1)

(2)

where max was the maximum eigenvalue and n represented the order of the matrix. Accordingly, the CR
was calculated by dividing the CI1 by the index for the
corresponding Random Index (RI) using the following
equation:

CI 1 = CI 1 /RI

(3)

100

(4)

where A1 to A
 7 represent each included modifiable risk
factor, as listed in Table 1. It should be noted that A1 to A7
can be values of 0 or 1, where 0 indicates the corresponding risk factor was not in effect and 1 indicates the corresponding risk factor was in effect (i.e., 0 = no exposure and
1 = exposure / risk exists). We calculated the corresponding z score for each geographical area (e.g., if the emitted
air pollution for a county is X tons/year, the corresponding value for A6 would be the corresponding z score which
is dependent on the average and variance of emitted air
pollution for that specific county compared to all other
counties in any state). Developed countries such as the US
do not rely on major sources of household air pollution—
kerosene, wood, or coal—to generate heat [61, 62], so A
 2 is
assigned a value of 0 for individuals living in these countries. The LCRI can take any value between 0 and 1: an
LCRI value of 0 means no predicted lung cancer risk (A1 to
A7 all equal 0), and an LCRI value of 1 represents the highest possible predicted risk of lung cancer.
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Case study
We test the adaptability and utility of the LCRI in a case
study performed using data for our home state of Illinois.
In this case study, we constructed the LCRIIL – a version
of the LCRI that reflects the available population-level
data in our state. IL is comprised of 102 counties, some
of which are urban and many of which are rural. Forty
percent of the state’s population resides in Cook County
– home to the City of Chicago. Cook County is the second-most populous county in the nation, with more than
5.2 million racially and ethnically diverse residents [63].
Our first step in creating the LCRIIL was to collect all
necessary risk factor data from publicly available data
sources. For all counties, we extracted data for 2014–
2019 for active smoking (percentage of adults who are
current smokers), radon exposure (pCi/L), outdoor
air pollution (concentration of fine particulate matter
(PM2.5)), and alcohol consumption (percentage of adults
reporting binge or heavy drinking in past 30 days) [64,
65]. There were no publicly available county-level data for
secondhand smoke exposure or occupational exposures,
so those risk factors were dropped from the LCRIIL.
The second step in creating the LCRIIL was to generate weights for each available risk factor using the previously described methods (see Methods, Steps 3a-3c). The
weights used in the LCRIIL were 0.70 for active smoking,
0.14 for alcohol consumption, 0.095 for outdoor air pollution, and 0.057 for radon exposure. The corresponding
equation to derive the LCRIIL is:
LCRI IL = 0.701B1 + 0.147B2 + 0.095B3 + 0.057B4
(5)
where B1 to B4 represent active smoking, alcohol consumption, outdoor air pollution, and radon exposure,
respectively. The CR of the AHP analysis for the case
study was 0.04, which indicated the consistency of the
analysis.
Figure 3 shows the prevalence of each individual risk
factor that was included in the L
 CRIIL, as well as lung
cancer outcomes [66], by county across Illinois. There is
substantial heterogeneity for each risk factor across the
state. Among the top 28 counties that have the highest
lung cancer incidence and / or mortality rates, eight are
also among the top 20 LCRIIL counties. These eight counties are predominantly located in rural areas (as defined
by the US census, [63]) of Southern and Southeastern Illinois, though one is an urban county located on the east
side of the state. Notably, Cook County had the highest
LCRIIL score but among the lowest lung cancer incidence
and mortality rates.
Table 2 presents Pearson correlation coefficients
between the L
 CRIIL z scores, active smoking, and lung
cancer incidence and mortality rates. The correlation
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coefficients between the LCRIIL and lung cancer incidence and mortality were 0.45 and 0.50, respectively, with
both p-values < 0.05. The correlation coefficient between
the LCRIIL and active smoking was high at 0.87, which
was expected given that this risk factor had the highest
assigned weight in the index.
In sensitivity analyses, we examined the magnitude
of the correlation coefficient for each component of the
LCRIIL in relation to lung cancer incidence and mortality rates. The correlation coefficient was only statistically
significant for active smoking, and the magnitude and
significance were similar to that of the L
 CRIIL (Table 3).
In an additional sensitivity analysis, alcohol consumption was dropped from the LCIRIL – since it is so highly
correlated with active smoking – and the resulting index
showed similar correlation with lung cancer incidence
and mortality rates (0.496 and 0.545, respectively) as
compared to the original index.

Discussion
We created a novel lung cancer risk index (LCRI) that
integrates multiple modifiable risk factors into one measure. Active smoking is the predominant risk factor for
lung cancer and is linked with 80–90% of lung cancer
deaths [25]. As expected, smoking received the highest weight in both our original index (LCRI: 46.1%) and
the one that we adapted for use in the state of Illinois
(LCRIIL: 70.1%). Conversely, radon exposure had the lowest weight in each index (LCRI: 3%, LCRIIL: 5.7%).
Previous studies have largely focused on associations
between individual risk factors and lung cancer outcomes
[11, 13, 25, 29]. However, there are laboratory, animal,
and human data showing that risk factors interact with
each other to affect cancer outcomes [67–69]. For example, Wu et al. [67] reviewed and highlighted the evidence
that cancer causation is multifactorial and suggested
that researchers consider the contributions of individual
factors and their joint effects on cancer burden. Li et al.
showed that gene-smoking interactions play important
roles in the etiology of lung cancer 68]. Our index represents an attempt to address these known interactions
by using population-based data to capture the combined
impact of multiple risk factors for lung cancer into one
measure.
Hot spots identified by our index share similar distribution patterns of risk factors from the geospatial analysis. Interestingly, Cook County has the highest LCRIIL
despite low adjusted lung cancer incidence and mortality rates. Although Cook County has moderate to high
levels of alcohol consumption, Fine Particulate Matter
2.5, and air pollution, it also has a high ratio of primary care physicians to the population (1050:1, ranked
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Fig. 3 Maps showing the prevalence of risk factors for each of Illinois’ 102 counties: a) active smoking (adults, 2014–2019), b) radon exposure
(2014–2019), c) excess alcohol consumption (adults, 2014–2019), d) outdoor air pollution (PM2.5, 2014–2019), e) Age-adjusted lung cancer
incidence rates (2014–2018), f) Age-adjusted lung cancer mortality rate (2014–2018), g) LCRI percentile

8th in IL), suggesting greater availability of healthcare
resources. This may explain the discordance between
Cook County’s LCRIIL and lung cancer incidence and
mortality rates. Counties with high L
 CRIIL and high
lung cancer incidence or mortality rates are mostly in

the rural area of the state with fewer available healthcare resources [70]. This echoes findings from recent
studies that cancer mortality rates associated with
modifiable risks were higher in rural compared with
urban populations [71, 72].
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Table 2 Results of Pearson correlation test between L CRIIL, percentage of active smokers, age-adjusted lung cancer incidence rate,
and age-adjusted lung cancer mortality rate

LCRIIL z score

LCRIIL z score

Active Smoker (%)

Age-Adjusted lung cancer Incidence
Rate (2014–2018)

Age-Adjusted lung cancer
mortality Rate (2014–
2018)

1

.869a

.449a

.495a

a

.498

.418a

1

.812a

Active Smoker (%)

1

Age-Adjusted lung cancer
Incidence Rate (2014–2018)
Age-Adjusted lung cancer
mortality Rate (2014–2018)
a

1

Correlation is significant at the 0.05 level (2-tailed)

Table 3 Sensitivity analysis of individual components of the LCRIIL in relation to lung cancer outcomes in Illinois
Age-adjusted IL lung cancer incidence
rate (2014—2018)
Active smoking

Air pollution (PM2.5)

Radon (pCi/L)

Excess alcohol consumption (%)

a

Age-adjusted lung cancer
mortality rate (2014—2018)

Pearson Correlation

.498a

.418a

Sig. (2-tailed)

0.000

0.000

N

102

102

Pearson Correlation

0.066

0.055

Sig. (2-tailed)

0.510

0.581

N

102

102

Pearson Correlation

-.124

-.126

Sig. (2-tailed)

0.510

0.581

N

102

102

Pearson Correlation

-.188

-0.063

Sig. (2-tailed)

0.825

-.187

N

102

102

Correlation is significant at the 0.05 level (2-tailed)

Cancer is a heterogeneous disease [73] with many
risk factors at individual and social levels. Our model
included the factors studied in the literature where
the studies met the criteria for inclusion (e.g., being a
modifiable risk factor, having an OR or RR, etc.); however, it is important to note that other non-modifiable
factors such as age, gender, and race have been shown
to also be strongly associated with lung cancer’s incidence and mortality rates [74]. Nevertheless, the study
offers a useful framework that health policymakers and
researchers can use to identify and examine potential
lung cancer risk factors for their geographical areas.
Our study has several strengths. First, to our knowledge, ours is the first study to use meta-analysis in combination with AHP to create a composite risk index for a
specific cancer. Second, our model summarized complex
and multi-dimensional factors to provide a tool for use
by healthcare decision-makers. Our index includes several major and minor modifiable risk factors rather than

a single biomedical factor. Third, our study presents a
new approach where researchers and policymakers can
utilize databases (e.g., U.S. Centers for Disease Control
& Prevention’s Behavioral Risk Factor Surveillance System, U.S. Environmental Protection Agency’s Office
of Air Quality Planning and Standards, etc.) at multiple geographic levels to identify areas that may benefit
from resource allocation and public health interventions.
Additionally, a Meta-AHP approach could potentially
be combined with machine learning and deep learning
models [75, 76] to analyze risk factors and predict health
outcomes more accurately.
There were several limitations to this study. First, the
AHP approach only allows for the inclusion of risk estimates greater than 1. As a result, we could not include
protective behaviors such as fruit and vegetable consumption in our index. Second, AHP relies directly and
exclusively on the magnitude of a single risk estimate
generated from the meta-analysis, which is likely an
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underestimate because the model does not allow for
variation in exposure prevalence by region. As an example, radon is widely considered to be the second leading cause of lung cancer, behind cigarette smoking [77].
However, as shown in Table 1, this risk factor received
the lowest weight in the index because the risk estimate from the meta-analysis was only 1.24–the smallest magnitude of any factor examined. Third, we could
not include secondhand smoke and occupational exposures in our tailored LCRIIL index because county-level
data in Illinois are not publicly available for these two
factors. We also did not include non-modifiable risk
factors such as age, gender, and race. Fourth, because
alcohol consumption and tobacco smoking are strongly
correlated, the confounding effect of smoking may
impact the weight of alcohol consumption in the LCRI.
However, when we removed alcohol consumption from
LCRIIL in a sensitivity test, the resulting index showed
similar correlation to lung cancer outcomes. Future
research is needed to examine the effect the strong correlation between smoking and alcohol has on the LCRI.
Fifth, we imposed a single cut point for each risk factor
in our models, while, in actuality, some risk factors may
exhibit curvilinear or other types of relationships with
cancer outcomes. Finally, the meta-analysis was limited
to literature published in 1990 and beyond, and therefore did not capture earlier studies.

Conclusion
We generated a lung cancer risk index that incorporated several modifiable risk factors into one composite
score. The index was driven heavily by active smoking, as
expected. In addition, the index was modestly correlated
with lung cancer outcomes in a case study conducted in
Illinois, demonstrating its adaptability and potential utility in numerous geographic locations and potentially in
many different fields. Future refinements to the index
could include adding other modifiable risk factors, examining the impact of non-modifiable risk factors such as
age, gender, and race / ethnicity in the LCRI, performing
geographical cluster analysis, and incorporating other
health behavior factors in AHP-based cancer risk factor
models for lung cancer or other health outcomes.
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